Home › Triple-Negative Breast Cancer › Maine
Pag-aaral pangklinika para sa Triple-Negative Breast Cancer sa Maine
3 pag-aaral para sa Triple-Negative Breast Cancer ang naghahanap ng mga kalahok sa mga site sa Maine.
Opisyal na teksto ng pag-aaral (English)
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- New England Cancer Specialists ( Site 0051), Westbrook
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06966700Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
- New England Cancer Specialists, Scarborough
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT05633654Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
- Eastern Maine Medical Center, Brewer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 29, 2026 · NCT04468061Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.